S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
NASDAQ:GRAY

Graybug Vision (GRAY) Stock Price, News & Analysis

$4.16
-0.03 (-0.72%)
(As of 03/28/2024 ET)
Today's Range
$3.89
$4.40
50-Day Range
$3.46
$7.44
52-Week Range
$5.00
$22.12
Volume
6,711 shs
Average Volume
2,165 shs
Market Capitalization
$6.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GRAY stock logo

About Graybug Vision Stock (NASDAQ:GRAY)

Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.

GRAY Stock Price History

GRAY Stock News Headlines

Best Vision Insurance Companies Of 2024
Bombshell 2024 election documentary
2024: America’s Last Election New documentary reveals why this could be America’s Last Election… and how the elites’ plan threatens to reset the entire U.S. economy, along with your 401(k), bank, and stock portfolio.
Best vision insurance companies of November 2023
Bombshell 2024 election documentary
2024: America’s Last Election New documentary reveals why this could be America’s Last Election… and how the elites’ plan threatens to reset the entire U.S. economy, along with your 401(k), bank, and stock portfolio.
Graybug Vision Stock (NASDAQ:GRAY), Dividends
Graybug Announces Name and Trading Symbol Change
GRAY Graybug Vision, Inc.
See More Headlines
Receive GRAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Graybug Vision and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/11/2021
Today
3/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:GRAY
Phone
N/A
Fax
N/A
Employees
27
Year Founded
N/A

Profitability

Net Income
$-35,600,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.67 per share

Miscellaneous

Free Float
20,250,000
Market Cap
$6.54 million
Optionable
Not Optionable
Beta
1.20
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Dr. Frederic Guerard Pharm.D. (Age 49)
    Pres, CEO, Sec. & Director
    Comp: $931.02k
  • Mr. Robert S. BreuilMr. Robert S. Breuil (Age 60)
    CFO & Treasurer
    Comp: $577.47k
  • Dr. Gerald D. Cagle Ph.D. (Age 78)
    Sr. Advisor & Head of Bus. Devel.
    Comp: $44.67k
  • Dr. Parisa Zamiri M.D. (Age 57)
    Ph.D., Chief Medical Officer
    Comp: $662.11k
  • Dr. Peter A. Campochiaro M.D.
    Co-Founder
  • Dr. Peter J. McDonnell M.D. (Age 63)
    Co-Founder
  • Ms. Bettina Maunz
    Chief People Officer & Head of Communications
  • Mr. Ming Yang
    Sr. VP of R&D
  • Dr. Ward M. Peterson Ph.D.
    Sr. VP of Preclinical Devel.
  • Mr. Ali Kakavand Ph.D.
    VP & Head of Program Management

GRAY Stock Analysis - Frequently Asked Questions

How have GRAY shares performed in 2024?

Graybug Vision's stock was trading at $2.86 on January 1st, 2024. Since then, GRAY shares have increased by 45.5% and is now trading at $4.16.
View the best growth stocks for 2024 here
.

How were Graybug Vision's earnings last quarter?

Graybug Vision, Inc. (NASDAQ:GRAY) issued its quarterly earnings results on Thursday, November, 11th. The company reported ($5.32) EPS for the quarter, missing analysts' consensus estimates of ($5.18) by $0.14.

When did Graybug Vision's stock split?

Graybug Vision's stock reverse split before market open on Monday, March 20th 2023. The 1-14 reverse split was announced on Monday, March 20th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, March 20th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

When did Graybug Vision IPO?

Graybug Vision (GRAY) raised $75 million in an IPO on Friday, September 25th 2020. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. SVB Leerink and Piper Sandler acted as the underwriters for the IPO and Needham & Co. and Wedbush PacGrow were co-managers.

How do I buy shares of Graybug Vision?

Shares of GRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GRAY) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners